Soleno Therapeutics (SLNO) Cash from Discontinued Operations (2016 - 2018)
Soleno Therapeutics (SLNO) reported Cash from Discontinued Operations of 188000.0 for Q4 2018, up 66.61% year-over-year from 112840.09 in Q4 2017, and up 53.58% quarter-over-quarter from 405000.0 in Q3 2018.
Soleno Therapeutics (SLNO) Cash from Discontinued Operations (2016 - 2018) Analysis & Trends
Soleno Therapeutics (SLNO) has 3 years of Cash from Discontinued Operations data on file, last reported at 188000.0 in Q4 2018.
- Cash from Discontinued Operations for Q4 2018 came in at 188000.0, up 66.61% year-over-year; the trailing twelve-month figure through Dec 2018 was 1361000.0 (up 55.1% YoY), and the FY2018 annual result was 1361000.0, up 55.1% from the prior year.
- Cash from Discontinued Operations climbed to 188000.0 in Q4 2018 per SLNO's latest filing, from 405000.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 188000.0 in Q4 2018 and troughed at 2783000.0 in Q3 2016.
- A 3-year average of 855927.2 and a median of 648000.0 in 2017 frame the typical range for Cash from Discontinued Operations.
- The sharpest annual moves came in 2017 and 2018: Cash from Discontinued Operations surged 73.66% in 2017, then soared 41.61% in 2018.
- A 3-year view of Cash from Discontinued Operations shows it stood at 1384272.0 in 2016, then soared by 59.33% to 563000.0 in 2017, then surged by 66.61% to 188000.0 in 2018.
- Business Quant data shows SLNO's Cash from Discontinued Operations at 188000.0 in Q4 2018, 405000.0 in Q3 2018, and 281000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -59.14 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -188,000.00 |
| Dec 31, 2018 | -188,000.00 |
| Sep 30, 2018 | -405,000.00 |
| Sep 30, 2018 | -405,000.00 |
| Jun 30, 2018 | -281,000.00 |
| Jun 30, 2018 | -281,000.00 |
| Mar 31, 2018 | -487,000.00 |
| Mar 31, 2018 | -487,000.00 |
| Dec 31, 2017 | -563,000.00 |
| Dec 31, 2017 | -563,000.00 |
| Sep 30, 2017 | -733,000.00 |
| Sep 30, 2017 | -733,000.00 |
| Jun 30, 2017 | -901,000.00 |
| Jun 30, 2017 | -901,000.00 |
| Mar 31, 2017 | -834,000.00 |
| Mar 31, 2017 | -834,000.00 |
| Dec 31, 2016 | -1.38 Mn |
| Dec 31, 2016 | -1.38 Mn |
| Sep 30, 2016 | -2.78 Mn |
| Sep 30, 2016 | -2.78 Mn |